The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Scott E. Hemby sits on this spectrum.
This scientist: 90 publications — 12th percentile
12% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Scott E. Hemby sits on this spectrum.
This scientist: 41 D-Index — 19th percentile
19% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Scott E. Hemby is affiliated with High Point University in the United States and specializes in neuroscience with a particular focus on pharmacology, organic chemistry, and cellular and molecular neuroscience. Their research integrates aspects of biochemistry and molecular biology, addressing complex biochemical processes and molecular signaling pathways.
Their scientific contributions cover significant topics including chemical synthesis and alkaloids, neurotransmitter receptor influence on behavior, and the pharmacological mechanisms of alkaloids. Additionally, their work involves traditional and medicinal uses of Annonaceae plants, receptor mechanisms and signaling, as well as plant pathogens and fungal diseases.
Frequent co-authors collaborating with Scott E. Hemby include Scot McIntosh, Nicholas H. Oberlies, Leia S. Stallings, Panos Roussos, and Chang-Gyu Hahn, each contributing to various multidisciplinary projects within their research scope.
Scott E. Hemby's publication record includes peer-reviewed articles in a range of scientific journals with a concentration of work in venues such as UNC Libraries, Molecular Psychiatry, Scientific Reports, Journal of Medicinal Chemistry, and Nature Communications.
These publications illustrate their involvement in areas such as drug interaction studies, therapeutic developments for substance use disorders, neuropharmacology, and natural product chemistry.
Susan M. Kaech;Scott Hemby;Ellen Kersh;Rafi Ahmed
Menachem Fromer;Panos Roussos;Solveig K. Sieberts;Jessica S. Johnson
Stephen D. Ginsberg;Scott E. Hemby;Virginia M.‐Y. Lee;James H. Eberwine
S. E. Hemby;Conchita Co;Timothy R. Koves;James E. Smith
Scott E. Hemby;Stephen D. Ginsberg;Brian Brunk;Steven E. Arnold
Gabriel E. Hoffman;Jaroslav Bendl;Georgios Voloudakis;Kelsey S. Montgomery
Nilesh S Tannu;Scott E Hemby
Stephen D. Ginsberg;Peter B. Crino;Scott E. Hemby;Jeremy A. Weingarten
Peter Crino;Kamran Khodakhah;Kevin Becker;Stephen Ginsberg
J Martin Verkuyl;Scott E Hemby;Marian Joëls
Scott E. Hemby;Scot McIntosh;Francisco Leon;Stephen J. Cutler
Amanda Dobbyn;Laura M Huckins;James Boocock;Laura G Sloofman
Willard M. Freeman;Scott E. Hemby
S E Hemby;T J Martin;C Co;S I Dworkin
Wendy J. Lynch;Kristen B. Piehl;Glen Acosta;Alexis B. Peterson
Wen Xue Tang;Wendy H. Fasulo;Deborah C. Mash;Scott E. Hemby
Scott E. Hemby;Conchita Co;Steven I. Dworkin;James E. Smith
Scott E. Hemby;John Q. Trojanowski;Stephen D. Ginsberg
Amir Abdolahi;Glen Acosta;Florence J. Breslin;Scott E. Hemby
Stephen D. Ginsberg;Irina Elarova;Marc Ruben;Fengzhu Tan
SE Hemby;GH Jones;Jr Jb Justice;DB Neill
If you think any of the details on this page are incorrect, let us know.
Chinese Academy of Sciences
The University of Texas at Austin
University of Ferrara
University of Toronto
Sheba Medical Center
University of Ulsan
Thomas Jefferson University
University of California, Los Angeles
Lawrence Berkeley National Laboratory
Tongji University
University of Granada
Dartmouth College
University of California, San Francisco
Nanjing Medical University
University of Edinburgh
Binghamton University
